 |
|
Newsletter sponsor
|
|
Indication
Preservative-free TIMOPTIC® in OCUDOSE® is indicated in
the treatment of elevated intraocular pressure in patients
with ocular hypertension or open-angle glaucoma.
Preservative-free TIMOPTIC® in OCUDOSE® may be used
when a patient is sensitive to the preservative in Timoptic
(timolol maleate ophthalmic solution), benzalkonium
chloride, or when use of a preservative-free topical
medication is advisable.
Important Safety Information
Timoptic is contraindicated in patients with: bronchial
asthma; a history of bronchial asthma; severe chronic
obstructive pulmonary disease; sinus bradycardia;
second or third degree atrioventricular block; overt
cardiac failure; cardiogenic shock; hypersensitivity to
any component of this product.
This drug is absorbed systemically. The same adverse
reactions found with systemic administration of betaadrenergic
blocking agents may occur with topical
administration. Severe respiratory or cardiac reactions,
including death, have been reported following systemic
or ophthalmic administration of timolol maleate.
Timoptic should be used with caution in patients
with cerebrovascular insufficiency.
The most frequently reported adverse experiences
have been burning and stinging upon instillation.
Click here for full Prescribing Information
| Sponsored by |
 |
© 2013 Valeant Ophthalmics, a division of Valeant Pharmaceuticals North America LLC
Bridgewater, NJ 08807 | LAC122-1112 |
|
